European Companies Search Engine
EU funding (€177,000): Dissecting the Role of HIF-Prolyl-Hydroxylase 2 (PHD2) in Breast Cancer Metastasis Identifying Novel Therapeutic Targets Fts1 Jul 2014 Financial Transparency System
Overview
Text
Project
| Subject of Grant or Contract | DISSECTING THE ROLE OF HIF-PROLYL-HYDROXYLASE 2 (PHD2) IN BREAST CANCER METASTASIS IDENTIFYING NOVEL THERAPEUTIC TARGETS |
| Responsible Department | REA - European Research Executive Agency |
| Programme Name | 1.1.1 - Seventh Research framework programme (including sixth Research framework programme) |
| Type of Contract* | Action Grant |
| Reference of the Legal Commitment (LC) | SI2.172936 |
| Management Type | Direct management |
| Geographical Zone | - |
| Budget | BGUE |
| Action Location | - |
| Commitment Total Amount (EUR) (A+B) | 177,000.00 |
| Project end Date | 13/10/2016 |
| Commitment Contracted Amount (EUR) (A) | 177,000.00 |
| Budget Line Name | People |
| Funding Type | Grant |
| Additional/Reduced Amount (EUR) (B) | 0.00 |
| Year | 2013 |
| Reference (Budget) | CPM.332363-1089811.1 |
| Commitment Consumed Amount (EUR) | 177,000.00 |
| Budget Line Number | 15 07 77 |
| Project Start Date | 01/07/2014 |
| Expense Type | Operational |
Beneficiaries
| Coordinator | Yes |
| Address | |
| Beneficiary’s Contracted Amount (EUR) | 177,000.00 |
| Beneficiary’s Estimated Contracted Amount (EUR) | 177,000.00 |
| Postal Code | 9052 |
| Beneficiary Country | Belgium |
| Beneficiary’s Estimated Consumed Amount (EUR) | 177,000.00 |
| VAT Number of Beneficiary | BE0456343923 |
| Beneficiary Group Code | LE05 |
| Not-for-Profit Organisation (Nfpo) | Yes |
| Beneficiary Type | Private Companies |
| Name of Beneficiary | VIB VZW*VLAAMS INSTITUUT BIOTECHNOLOGIE FLANDERS INSTITUTE FOR BIOTECHNOLOGY |
| Nuts2 | Prov. Oost-Vlaanderen |
| City | ZWIJNAARDE |
| Non-Governmental Organisation (NGO) | Yes |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium.
The visualizations for "VIB VZW - EU funding (€177,000): Dissecting the Role of HIF-Prolyl-Hydroxylase 2 (PHD2) in Breast Cancer Metastasis Identifying Novel Therapeutic Targets"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
